Who will win Canada’s cold‑chain race?

Canada’s two largest cargo gateways, Toronto Pearson and Montréal–Trudeau, are expanding their cold-chain capabilities to capture growing pharmaceutical and biologics demand. Toronto leverages scale, automation, and network reach to serve high-volume, globally distributed pharma flows, while Montreal focuses on speed, proximity to manufacturing, and handling precision for time- and temperature-critical shipments. Both gateways are strengthening Canada’s role as a re-export and risk-diversification corridor for US-bound pharma cargo in 2026.